Enrofloxacin is a synthetic, broad spectrum antimicrobial substance, bactericidal in action with efficacy against a wide range of gram positive and gram negative bacteria and mycoplasmas.

The product is indicated for the treatment of bovine respiratory disease associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somnus and Mycoplasma species, where clinical experience, supported where possible, by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.